New study confirms staggering racial disparities in COVID-19 cases in Massachusetts
The pandemic produced a ’perfect storm’ of factors for communities of color.
The pandemic produced a ’perfect storm’ of factors for communities of color.
Alexa B. Kimball, MD, MPH (President & CEO, Harvard Medical Faculty Physicians at BIDMC) discusses how hospitals are preparing for a potential second surge of COVID-19, and why colder months present more of a challenge in terms of social distancing.
Alexa B. Kimball, MD, MPH (President & CEO, Harvard Medical Faculty Physicians at BIDMC) and other healthcare professionals put together a checklist of what Massachusetts still needs to prepare for a potential second surge of COVID-19 cases.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses how we might develop immunity to COVID-19, noting that it would take time.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the first documented case of COVID-19 reinfection.
C. Michael Gibson (Cardiology, BIDMC) discusses the FDA issuing an emergency use authorization of convalescent plasma for the treatment of COVID-19.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses “Operation Warp Speed” which has allocated nearly $11 billion to pharmaceutical companies to accelerate the discovery and production of a COVID-19 vaccine.
Russia's plan to roll-out a COVID-19 vaccine before full trial results is prompting concern among virus experts, who warn a partially effective shot may encourage the novel coronavirus to mutate. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) notes that mutation rates for COVID-19 are far lower than viruses like HIV, but there are downsides to using a vaccine that doesn’t work.
As patients avoided hospitals and doctors’ offices, conditions like cancer and heart disease went untreated. Health care providers now stress the importance of non-COVID-19 care as the pandemic stretches on.
